Entasis Therapeutics Holdings Inc. (44) | Human Resources (19)

Browse by Subcategory

Recent Contracts

Form of Retention Bonus Award Memo (Filed With SEC on March 3, 2022)
Second Amended Non-Employee Director Compensation Policy, as amended January 1, 2022 (Filed With SEC on March 3, 2022)
Employment Agreement between the Company and Eric Kimble, effective September 6, 2019 (Filed With SEC on May 7, 2020)
Amendment to Incentive Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
Amended Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
Amended Stock Option Agreement under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
Amendment to Restricted Stock Unit Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
Amendment to Stock Option Agreements under the 2018 Equity Incentive Plan (Filed With SEC on March 3, 2022)
Amendment to Nonqualified Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
Amendment to Nonqualified Stock Option Agreement for employees under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
Amendment to Incentive Stock Option Agreement for senior management under the 2015 Stock Incentive Plan (Filed With SEC on March 3, 2022)
Form of Restricted Stock Unit Grant Notice (Performance-Based) (Filed With SEC on November 6, 2020)
First Amendment to 2018 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Special Bonus Award Memorandum, dated May 15, 2020 (Filed With SEC on August 6, 2020)
Amended Non-employee Director Compensation Policy, as amended December 6, 2019 (Filed With SEC on August 6, 2020)
Non-employee Director Compensation Policy, as amended June 19, 2019 (Filed With SEC on May 7, 2020)
Form of Executive Officer Employment Agreement (Filed With SEC on May 7, 2020)
Non-Employee Director Compensation Policy (Filed With SEC on March 11, 2020)
Employment Agreement between the Company and Ruben Tommasi, effective September 25, 2018 (Filed With SEC on March 29, 2019)